No evidence for deletions of the NBS1 gene in lymphomas

Citation
P. Stumm et al., No evidence for deletions of the NBS1 gene in lymphomas, CANC GENET, 126(1), 2001, pp. 60-62
Citations number
13
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER GENETICS AND CYTOGENETICS
ISSN journal
01654608 → ACNP
Volume
126
Issue
1
Year of publication
2001
Pages
60 - 62
Database
ISI
SICI code
0165-4608(20010401)126:1<60:NEFDOT>2.0.ZU;2-D
Abstract
Patients with Nijmegen breakage syndrome (NBS) have a high risk to develop malignant diseases. most frequently B-cell lymphomas. The NBS gene product, nibrin, is involved in DNA recombination repair, a function shared with kn own tumor suppressor genes like BRCA1 and BRCA2. This led us to investigate whether NBS acts as tumor suppressor gene in the development of non-Hodgki n lymphomas. Therefore, we performed fluorescence in situ hybridization ana lysis using a BAC clone containing the entire NBS1 region on eight B-cell a nd eight T-cell lymphomas, including one B-cell and two T-cell lymphomas wi th structural abnormalities of 8q. None of the tumors showed a deletion of the NBS1 gene, demonstrating that deletion of the NBS1 gene is not a major cause or a primary event in tumorigenesis of human B- and T-cell lymphomas. (C) 2001 Elsevier Science Inc. All rights reserved.